Your browser doesn't support javascript.
loading
Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
Pietersen, Elize; Anderson, Kim; Cox, Helen; Dheda, Keertan; Bian, Aihua; Shepherd, Bryan E; Sterling, Timothy R; Warren, Robin M; van der Heijden, Yuri F.
Affiliation
  • Pietersen E; Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, Division of Pulmonology, Centre for Lung Infection and Immunity, University of Cape Town, Cape Town, South Africa.
  • Anderson K; Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, Division of Pulmonology, Centre for Lung Infection and Immunity, University of Cape Town, Cape Town, South Africa.
  • Cox H; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
  • Dheda K; Wellcome Centre for Infectious Diseases Research in Africa and the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Bian A; Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, Division of Pulmonology, Centre for Lung Infection and Immunity, University of Cape Town, Cape Town, South Africa.
  • Shepherd BE; Faculty of Infectious and Tropical Diseases, Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Sterling TR; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Warren RM; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • van der Heijden YF; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
PLoS One ; 18(2): e0281097, 2023.
Article in En | MEDLINE | ID: mdl-36780443
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Aminosalicylic Acid / HIV Infections / Tuberculosis, Multidrug-Resistant / Mycobacterium tuberculosis Type of study: Guideline / Observational_studies / Risk_factors_studies Country/Region as subject: Africa Language: En Journal: PLoS One Year: 2023 Type: Article Affiliation country: South Africa
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Aminosalicylic Acid / HIV Infections / Tuberculosis, Multidrug-Resistant / Mycobacterium tuberculosis Type of study: Guideline / Observational_studies / Risk_factors_studies Country/Region as subject: Africa Language: En Journal: PLoS One Year: 2023 Type: Article Affiliation country: South Africa